As on Wednesday, TG Therapeutics Inc (NASDAQ: TGTX) got off with the flyer as it spiked 2.74% to $31.15, before settling in for the price of $30.32 at the close. Taking a more long-term approach, TGTX posted a 52-week range of $11.86-$36.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 2506.46% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is -40.74%. This publicly-traded company’s shares outstanding now amounts to $151.42 million, simultaneously with a float of $140.42 million. The organization now has a market capitalization sitting at $4.85 billion. At the time of writing, stock’s 50-day Moving Average stood at $25.16, while the 200-day Moving Average is $19.51.
TG Therapeutics Inc (TGTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. TG Therapeutics Inc’s current insider ownership accounts for 9.79%, in contrast to 65.33% institutional ownership. According to the most recent insider trade that took place on Nov 11 ’24, this organization’s Director sold 5,000 shares at the rate of 30.44, making the entire transaction reach 152,200 in total value, affecting insider ownership by 100,195. Preceding that transaction, on Nov 11 ’24, Company’s Director sold 25,000 for 30.20, making the whole transaction’s value amount to 754,875. This particular insider is now the holder of 212,479 in total.
TG Therapeutics Inc (TGTX) Earnings and Revenue Records
TG Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -40.74% and is forecasted to reach 0.97 in the upcoming year.
TG Therapeutics Inc (NASDAQ: TGTX) Trading Performance Indicators
Let’s observe the current performance indicators for TG Therapeutics Inc (TGTX). It’s Quick Ratio in the last reported quarter now stands at 3.91. The Stock has managed to achieve an average true range (ATR) of 2.10. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 18.31.
In the same vein, TGTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.11, a figure that is expected to reach 0.09 in the next quarter, and analysts are predicting that it will be 0.97 at the market close of one year from today.
Technical Analysis of TG Therapeutics Inc (TGTX)
Through scrutinizing the latest numbers posted by the [TG Therapeutics Inc, TGTX], it can be observed that its last 5-days Average volume of 4.03 million was better the volume of 3.7 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 37.04% While, its Average True Range was 2.31.
Raw Stochastic average of TG Therapeutics Inc (TGTX) in the period of the previous 100 days is set at 73.05%, which indicates a major rise in contrast to 60.60% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 100.47% that was higher than 66.95% volatility it exhibited in the past 100-days period.
